As of April 2024 Marksans Pharma has a market cap of $0.94 Billion. This makes Marksans Pharma the world's 5152th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.94 B | 9.54% |
2023 | $0.86 B | 205.87% |
2022 | $0.28 B | -14.48% |
2021 | $0.33 B | -2.55% |
2020 | $0.33 B | 254.12% |
2019 | $95.85 M | -41.2% |
2018 | $0.16 B | -36.13% |
2017 | $0.25 B | 6.31% |
2016 | $0.24 B | -62.77% |
2015 | $0.64 B | 72.62% |
2014 | $0.37 B | 240.34% |
2013 | $0.10 B | 380.6% |
2012 | $22.83 M | 93.6% |
2011 | $11.79 M | -61.15% |
2010 | $30.37 M | -32.78% |
2009 | $45.18 M | -17.23% |
2008 | $54.58 M | -80.82% |
2007 | $0.28 B | 223.34% |
2006 | $88.01 M |
On Apr 18th, 2024 the market cap of Marksans Pharma was reported to be: